NUCANA PLC
Research and experimental development on biotechnology
NUCANA PLC
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
77 78 Cannon Street London EC4N 6AF England
Full company profile for NUCANA PLC (03308778), an active life sciences and medical technology company based in London, England. Incorporated 28 Jan 1997. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2017–2024)
Cash in Bank
£6.75M
Net Assets
£5.95M
Total Liabilities
£8.82M
Turnover
N/A
Employees
N/A
Debt Ratio
60%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 5 funding rounds
Sign up to view complete fundraising history
Investors (9)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 6 | Nov 2011 | Series B, Series A |
| Investor 7 | Nov 2011 | Series B, Series A |
| Investor 9 | Nov 2011 | Series A |
See all 9 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||||
|---|---|---|---|---|---|---|---|
No officers found | |||||||
No officers found
See all 21 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
Sofinnova Partners Sas
Ceased 2 Oct 2017
Group Structure
Group Structure
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 11 Feb 2026 | Confirmation Statement | Confirmation statement made on 2026-01-28 with updates | |
| 9 Feb 2026 | Officers | Change to director Mr Cyrille Raymond George Leperlier on 2018-05-01 | |
| 4 Nov 2025 | Officers | Termination of Bali Muralidhar as director on 2025-10-21 | |
| 1 Aug 2025 | Capital | Allotment of shares (GBP 14,340,128.3) on 2025-07-30 | |
| 30 Jul 2025 | Capital | Allotment of shares (GBP 14,284,757.84) on 2025-07-29 |
Confirmation statement made on 2026-01-28 with updates
Change to director Mr Cyrille Raymond George Leperlier on 2018-05-01
Termination of Bali Muralidhar as director on 2025-10-21
Allotment of shares (GBP 14,340,128.3) on 2025-07-30
Allotment of shares (GBP 14,284,757.84) on 2025-07-29
Recent Activity
Latest Activity
Confirmation statement made on 2026-01-28 with updates
2 months ago on 11 Feb 2026
Change to director Mr Cyrille Raymond George Leperlier on 2018-05-01
2 months ago on 9 Feb 2026
Termination of Bali Muralidhar as director on 2025-10-21
5 months ago on 4 Nov 2025
Allotment of shares (GBP 14,340,128.3) on 2025-07-30
8 months ago on 1 Aug 2025
Allotment of shares (GBP 14,284,757.84) on 2025-07-29
8 months ago on 30 Jul 2025